Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV negative women
Kristine B. Patterson(University of North Carolina at Chapel Hill), Craig Sykes(University of North Carolina at Chapel Hill), Benjamin N. Greener(University of North Carolina at Chapel Hill), Julie B. Dumond(University of North Carolina at Chapel Hill), Jessica Adams(University of North Carolina at Chapel Hill), Heather Prince(Edwards Lifesciences (United States)), Angela D. M. Kashuba(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
|Science Translational Medicine|2011|352
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
|The Journal of Infectious Diseases|2016|303
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1
|Annals of Internal Medicine|2014|262
Lopinavir/Ritonavir Induces the Hepatic Activity of Cytochrome P450 Enzymes CYP2C9, CYP2C19, and CYP1A2 But Inhibits the Hepatic and Intestinal Activity of CYP3A as Measured by a Phenotyping Drug Cocktail in Healthy Volunteers
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|193